SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1552the other half ?osofun-12/21/2007
1551Half of that could be rollouts from Dec 7.5P. And it seems a decent write for rIRWIN JAMES FRANKEL-12/21/2007
1550notice jan 7.50 puts ( alot of activity )osofun-12/21/2007
1549ARYX CC post-mortem and quiz: siliconinvestor.comDewDiligence_on_SI-12/20/2007
1548please tel what you think about this stock. New, although quite abit of money inosofun-12/16/2007
1547SI flat in the latest data at ~4.5MIRWIN JAMES FRANKEL-12/11/2007
1546>> Can't tell whether these are buys or sells. Buys would be consisteIRWIN JAMES FRANKEL-12/10/2007
1545Another high volume day for the Jan 7.50 calls - 969 contracts. Eyeballing thIan@SI-12/10/2007
1544Race Is on for the Next Blood Thinner Drugs Are in Advanced Testing But Safety Doc Bones-12/10/2007
1543To keep things from getting too complicated, I generally consider such drugs as DewDiligence_on_SI-12/9/2007
1542>> The sales potential of some of these anticoagulants is enormous. It makIRWIN JAMES FRANKEL-12/9/2007
1541Thanks also for the indexed link. You are probably aware, but if not, SGP is Biotech Jim-12/9/2007
1540<i>Thanks for the indexed links, too.</i> The sales potential of soDewDiligence_on_SI-12/9/2007
1539Ah, yes, that's a good answer. Thanks for the indexed links, too. Cheers, tuck-12/9/2007
1538Anticoagulant index: siliconinvestor.comDewDiligence_on_SI-12/9/2007
1537BI Starts Phase-2 Trial of Dabigatran in ACS: siliconinvestor.comDewDiligence_on_SI-12/9/2007
1536<i>A legitimate question for management would be "How is M118 better DewDiligence_on_SI-12/8/2007
1535Top-line data from the Rivaroxaban study in today’s JNJ PR were reported in JulyDewDiligence_on_SI-12/8/2007
1534Very much on topic. According to the link below, Rivaroxaban is reversible -- atuck-12/8/2007
1533Rivaroxaban better than Sanofi's Lovenox - study Sat Dec 8, 2007 10:00am ESTThe Dodgy Ticker-12/8/2007
1532and some solid option volume for the 7.50 calls right out to Mar and also the JaIan@SI-12/7/2007
1531Incredible 2 day move. Of course I sold half my position for tax loss purposes.Rocky9-12/7/2007
1530Does anyone have any speculation on what the other follow-on biologics in the Saghmm-11/30/2007
1529The options chains don't show much, other than largish OI in December and Jatuck-11/29/2007
1528April!!!??? Gosh darn it! Thanks for the info RJ you are the best!Go Market Go!-11/29/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):